Testing effectiveness (Phase 2)Ended earlyNCT05055258
What this trial is testing
A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II
Who this might be right for
Angioedema, Hereditary, Types I and II
KalVista Pharmaceuticals, Ltd. 33